Literature DB >> 1968433

Enrichment of suppressor T cells by means of binding to monophosphoryl lipid A.

P J Baker1, K R Haslov, M B Fauntleroy, P W Stashak, K Myers, J T Ulrich.   

Abstract

The binding and elution of spleen cells from plastic dishes coated with monophosphoryl lipid A (MPL) resulted in a greater than 1,000-fold enrichment of antigen-specific suppressor T-cell (TS) activity when spleen cells from mice 18 to 24 h after exposure to a low dose of type III pneumonococcal polysaccharide (SSS-III) were used. The removal of MPL-adherent TS cells resulted in an increase in the degree of amplifier T-cell (TA) activity present in the remaining MPL-nonadherent cell fraction; however, both TS and TA activities were found in the MPL-adherent cell fraction when spleen cells from mice 4 days after immunization with an optimal dose of SSS-III were examined. These findings, as well as others, suggest that both TS and TA, once activated, acquire a cell surface receptor that enables them to bind to MPL. Because of differences in the kinetics for the activation of TS and TA during the course of the antibody response and the fact that TS, but not TA, activity appears as early as 18 to 24 h after exposure to SSS-III, it is possible to use this experimental approach to obtain cell suspensions greatly enriched in TS activity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1968433      PMCID: PMC258525          DOI: 10.1128/iai.58.3.726-731.1990

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  22 in total

1.  Kinetics of the antibody response to type III pneumococcal polysaccharide (SSS-III). I. Use of 125I-labeled SSS-III to study serum antibody levels, as well as the distribution and excretion of antigen after immunization.

Authors:  J M Jones; D F Amsbaugh; B Prescott
Journal:  J Immunol       Date:  1976-01       Impact factor: 5.422

Review 2.  Homeostatic control of antibody responses: a model based on the recognition of cell-associated antibody by regulatory T cells.

Authors:  P J Baker
Journal:  Transplant Rev       Date:  1975

3.  Two defects in old New Zealand Black mice are involved in the loss of low-dose paralysis to type III pneumococcal polysaccharide.

Authors:  K L McCoy; P J Baker; P W Stashak; T M Chused
Journal:  J Immunol       Date:  1985-10       Impact factor: 5.422

4.  Studies on the induction and expression of T cell-mediated immunity. X. Inhibition by Lyt 2,3 antisera of cytotoxic T lymphocyte-mediated antigen-specific and -nonspecific cytotoxicity: evidence for the blocking of the binding between T lymphocytes and target cells and not the post-binding cytolytic steps.

Authors:  J Fan; A Ahmed; B Bonavida
Journal:  J Immunol       Date:  1980-12       Impact factor: 5.422

5.  Beneficial modification of the endotoxin molecule.

Authors:  E Ribi
Journal:  J Biol Response Mod       Date:  1984

6.  Direct evidence for the involvement of T suppressor cells in the expression of low-dose paralysis to type III pneumococcal polysaccharide.

Authors:  P J Baker; D F Amsbaugh; P W Stashak; G Caldes; B Prescott
Journal:  J Immunol       Date:  1982-03       Impact factor: 5.422

7.  Cell surface antigens and other characteristics of T cells regulating the antibody response to type III pneumococcal polysaccharide.

Authors:  C E Taylor; D F Amsbaugh; P W Stashak; G Caldes; B Prescott; P J Baker
Journal:  J Immunol       Date:  1983-01       Impact factor: 5.422

8.  Regulation of the antibody response to pneumococcal polysaccharide by thymus-derived cells.

Authors:  P J Baker; D F Amsbaugh; P W Stashak; G Caldes; B Prescott
Journal:  Rev Infect Dis       Date:  1981 Mar-Apr

9.  Influence of multiple genes on the magnitude of the antibody response to bacterial polysaccharide antigens.

Authors:  P J Baker; J A Rudbach; B Prescott; G Caldes; C Evans; P W Stashak
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

10.  Activation of antigen-specific suppressor T cells by B cells from mice immunized with type III pneumococcal polysaccharide.

Authors:  C E Taylor; P W Stashak; G Caldes; B Prescott; T E Chused; A Brooks; P J Baker
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307

View more
  6 in total

Review 1.  Regulation of magnitude of antibody response to bacterial polysaccharide antigens by thymus-derived lymphocytes.

Authors:  P J Baker
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

2.  Inactivation of suppressor T cell activity by the nontoxic lipopolysaccharide of Rhodopseudomonas sphaeroides.

Authors:  P J Baker; C E Taylor; P W Stashak; M B Fauntleroy; K Hasløv; N Qureshi; K Takayama
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

3.  Structural features that influence the ability of lipid A and its analogs to abolish expression of suppressor T cell activity.

Authors:  P J Baker; T Hraba; C E Taylor; K R Myers; K Takayama; N Qureshi; P Stuetz; S Kusumoto; A Hasegawa
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

4.  Abrogation of suppression of delayed hypersensitivity induced by Candida albicans-derived mannan by treatment with monophosphoryl lipid A.

Authors:  J E Domer; L G Human; G B Andersen; J A Rudbach; G L Asherson
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

5.  Antigen-specific suppressor T cells respond to recombinant interleukin-2 and other lymphokines.

Authors:  C E Taylor; M B Fauntleroy; P W Stashak; P J Baker
Journal:  Infect Immun       Date:  1991-02       Impact factor: 3.441

6.  Differential effects of monophosphoryl lipid A on expression of suppressor T cell activity in lipopolysaccharide-responsive and lipopolysaccharide-defective strains of C3H mice.

Authors:  F S Ekwunife; C E Taylor; M B Fauntleroy; P W Stashak; P J Baker
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.